Elevance Health issues $1.8B of notes in three tranches at 5.35%-6.10%

Elevance Health, Inc.

$400M 5.350% notes due 2025, $650M 5.500% notes due 2032, $750M 6.100% notes due 2052.
Net proceeds of approx. $1.7802B after underwriting discounts and offering expenses.
Intends to use proceeds for working capital, acquisitions, debt repayment, and share repurchases.
Underwriters: BofA Securities and Deutsche Bank Securities as representatives.
Notes registered under Form S-3; interest semi-annual beginning April 15, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.